Agenus to Host End-of-Year Stakeholder Webcast Featuring GI Oncology Leaders and Progress of BOT/BAL
Agenus Inc. ("Agenus") (Nasdaq: AGEN), a leader in immuno-oncology, today announced it will host its End-of-Year 2025 Stakeholder Webcast on Wednesday, December 3, 2025 at 4:00 p.m. ET. The session ...
Every year, several people across India are hit with the devastating news of a cancer diagnosis, leaving them grappling with uncertainty and emotional turmoil .
A recent analysis reveals that monthly prices of checkpoint inhibitors decreased only a small amount over a decade.
Movember highlights rising prostate and testicular cancer risks worldwide, urging men to screen early and support awareness ...
Detailed price information for Oncolytics Biotech Inc (ONCY-Q) from The Globe and Mail including charting and trades.
The Inflation Reduction Act (IRA) of 2022 mandates price negotiations for certain drugs under Medicare, shortening the exclusivity period historically used to recoup research and development ...
Jefferies London Healthcare Conference 2025 November 18, 2025 8:00 AM ESTCompany ParticipantsSteve Chapman - CEO & ...
For many men, the idea that something as ordinary as ejaculation could help prevent prostate cancer sounds almost too simple ...
Regulators approved the injection, which significantly cuts administration time versus the intravenous formulation, based on a Phase III comparison of the two.
UCLA research finds that fewer than one in four eligible younger adults completed colorectal cancer screenings after the ...
News-Medical.Net on MSN
AI analysis of biopsy slides predicts rectal cancer treatment response
Artificial intelligence (AI) can predict how well patients with rectal cancer will respond to treatment by analyzing standard tissue samples taken during diagnosis, finds a new study from researchers ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results